| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Dept of Communicable Disease Control and Prevention, Stockholm County, and 2 Dept of Infectious Diseases, Karolinska Institutet, Karolinska Hospital, S-171 76, Stockholm, Sweden
CORRESPONDENCE: Å. Örtqvist, Dept of Communicable Diseases and Prevention, Norrbacka, Karolinska Hospital, SE-171 76, Stockholm, Sweden. Fax: 46 8315767. E-mail: ake.ortqvist@sme.sll.se
Keywords: elderly, influenza vaccine, pneumococcal vaccine
Received: June 5, 2003
Accepted September 16, 2003
This study was supported financially by Stockholm City Council, The Swedish Heart-Lung Foundation, and Karolinska Institutet.
In 1999, all individuals
Vaccination was performed in 124,702 (48%) subjects; 72,107 had both vaccines, 29,346 only had the influenza vaccine and 23,249 only had the pneumococcal vaccine. Compared with the unvaccinated cohort, a lower incidence of hospitalisation for all end-point diagnoses was seen in vaccinated persons.
An additive effectiveness of vaccination was seen when both vaccines were given, with a reduction of hospital admissions for influenza (37%), pneumonia (29%) and IPD (44%). In-hospital mortality for pneumonia was significantly lower in those who received both vaccines, than in unvaccinated persons.
To conclude, vaccination with influenza and pneumococcal vaccines together was effective in reducing the need for hospital admission for influenza and pneumonia. There was a strong indication that pneumococcal vaccination alone, was effective not only in the prevention of invasive pneumococcal disease, but also of pneumonia overall, although to a low degree.
65 yrs of age (n=258,754) in Stockholm County, Sweden, were offered influenza and pneumococcal vaccination in a prospective study on the effectiveness of these vaccines in reducing the need for hospital treatment and death due to influenza, pneumonia and invasive pneumococcal disease (IPD). Data on hospitalisation and mortality during 1 yr were obtained from the administrative database in Stockholm County Council.
This article has been cited by other articles:
|
|
 |
|
  A Sliedrecht, W P J den Elzen, T J M Verheij, R G J Westendorp, and J Gussekloo Incidence and predictive factors of lower respiratory tract infections among the very elderly in the general population. The Leiden 85-plus Study Thorax, September 1, 2008; 63(9): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Johnstone, T. J. Marrie, D. T. Eurich, and S. R. Majumdar Effect of Pneumococcal Vaccination in Hospitalized Adults With Community-Acquired Pneumonia Arch Intern Med, October 8, 2007; 167(18): 1938 - 1943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Kapetanovic, T. Saxne, J.-A. Nilsson, and P. Geborek Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients Rheumatology, April 1, 2007; 46(4): 608 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. File Jr and J. S. Tan Pneumonia in Older Adults: Reversing the Trend JAMA, December 7, 2005; 294(21): 2760 - 2763. [Full Text] [PDF]
|
|
|
|
 |
|
 A. de Roux and H. Lode Pneumococcal vaccination Eur. Respir. J., December 1, 2005; 26(6): 982 - 983. [Full Text] [PDF]
|
|
|
|
|
|
A. Vila-Corcoles, O. Ochoa-Gondar, C. Llor, I. Hospital, T. Rodriguez, and A. Gomez Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Eur. Respir. J., December 1, 2005; 26(6): 1086 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shi, T. Yamazaki, Y. Okubo, Y. Uehara, K. Sugane, and K. Agematsu Regulation of Aged Humoral Immune Defense against Pneumococcal Bacteria by IgM Memory B Cell J. Immunol., September 1, 2005; 175(5): 3262 - 3267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Combined Influenza and Pneumococcal Vaccination: A Success Story Journal Watch Infectious Diseases, March 29, 2004; 2004(329): 4 - 4. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
